SHE/300759 (SHE/300759)

Shenzhen Stock Exchange: SHE/300759 · CNY

CN¥39.6

+2.35 (+6.3%)· Recorded snapshot

Market cap	66.7B
Revenue (ttm)	16B
Net income (ttm)	1.8B
EPS (ttm)	CN¥0.97
Shares out	1.8B
P/E (trailing)	40.7x
P/E (forward)	24.1x
Dividend	CN¥0.20 (0.51%)
Volume	50,001,202
Beta	0.68

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 16B
Net income (ttm): 1.8B
EPS (ttm): CN¥0.97
P/E (trailing): 40.7x
P/E (forward): 24.1x
Market cap: 66.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E24.1

P25 n/aP50 n/aP75 n/a

Trailing P/E40.7

P25 n/aP50 n/aP75 n/a

ROE10.4

P25 n/aP50 n/aP75 n/a

ROIC8.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SHE/300759 indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

CNY

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CNY
Country	China
Country code	CN
Earnings date	2026-10-27
Employees	27,316
Employees change	2,228
Employees growth	8.88%
Enterprise value	CNY 70.8B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CNE100003JW4
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2023-07-27
Last stock split type	Forward
Market cap	CNY 66.7B
Next earnings date	2026-10-28
Price	CNY 39.60
Price currency	CNY
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	she/300759
Website	https://www.pharmaron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	53.13x
Average P/E ratio (3Y)	28.09x
Average P/E ratio (5Y)	35.46x
Earnings yield	2.46%
EV/Earnings	40.02x
EV/EBIT	30.06x
EV/EBITDA	19.55x
EV/Sales	4.42x
FCF / EV yield	-0.4%
FCF yield	-0.42%
Forward P/E	24.07x
Graham number	14.23072
Graham upside	-64.06%
Industry forward P/E	37.25x
Lynch fair value	CNY 4.87
Lynch upside	-87.71%
P/B ratio	3.79x
P/E ratio	40.69x
P/OCF ratio	24.78x
P/S ratio	4.17x
PEG ratio	1.32x
Price / tangible book value	5.48x
Price/EBITDA ratio	19.28x
Sector forward P/E	20.26x
Sector P/E	37.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.72%
EBITDA margin	21.61%
Effective tax rate	19.94%
Gross margin	33.66%
Operating margin	14.72%
Pretax margin	13.25%
Profit margin	11.05%
Profit per employee	CNY 64,801
Profitable quarters	35
Profitable years	12
Revenue per employee	CNY 586,206
ROA	5.08%
ROA (5Y)	5.02%
ROCE	11.18%
ROE	10.37%
ROE (5Y)	13.13%
ROIC	8.86%
ROIC (5Y)	10.85%
Tax / revenue	2.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	13.69%
EPS growth (Q)	8.89%
EPS growth (QoQ)	19.87%
EPS growth 3Y	3.6%
EPS growth 5Y	4.08%
EPS growth quarters	4
EPS growth years	0
Gross profit growth	15.93%
Gross profit growth (Q)	16.19%
Gross profit growth 3Y	9.19%
Gross profit growth 5Y	16.57%
Net income growth	17.04%
Net income growth (Q)	13.06%
Net income growth (QoQ)	19.79%
Net income growth 3Y	4.47%
Net income growth 5Y	4.46%
Net income growth quarters	4
Net income growth years	0
OCF growth	-16.98%
OCF growth (Q)	-20.01%
OCF growth (QoQ)	71.21%
OCF growth 3Y	-1.04%
OCF growth 5Y	7.15%
Operating income growth	19.11%
Operating income growth (Q)	47.35%
Operating income growth 3Y	10.9%
Operating income growth 5Y	11.6%
Revenue growth	18.23%
Revenue growth (Q)	20.94%
Revenue growth (QoQ)	9.73%
Revenue growth 3Y	11.91%
Revenue growth 5Y	18.51%
Revenue growth quarters	9
Revenue growth years	11

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CNY -3B
Depreciation and amortization	CNY 1.1B
EBIT	CNY 2.4B
EBITDA	CNY 3.5B
EPS	CNY 0.97
FCF per share	CNY -0.15
Financing cash flow	CNY 3.6B
Free cash flow	CNY -282.9M
Gross profit	CNY 5.4B
Income taxes	CNY 423.1M
Investing cash flow	CNY -4.8B
Net borrowing	CNY 3.1B
Net cash flow	CNY 1.5B
Net income	CNY 1.8B
Operating income	CNY 2.4B
Revenue	CNY 16B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CNY 9.25
Debt / EBITDA	2.06
Debt / equity	0.42
Goodwill	CNY 3.5B
Interest coverage	46.08
Long-term assets	CNY 20.7B
Long-term liabilities	CNY 3.5B
Net cash (debt)	CNY -3.4B
Net cash / market cap	-5.15%
Net debt / EBITDA	0.99
Net debt / equity	0.2
Piotroski F-Score	6
Property, plant and equipment	CNY 13.1B
Shareholders' equity	CNY 17.6B
Tangible book value	CNY 12.2B
Tangible book value per share	CNY 6.66
Total assets	CNY 32.2B
Total cash	CNY 4B
Total debt	CNY 7.5B
Total liabilities	CNY 14.7B
WACC	7.25%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.55
Current assets	CNY 11.6B
Current liabilities	CNY 11.2B
Current ratio	1.04
Inventory turnover	5.9
Net working capital	CNY 1.3B
Quick ratio	0.69
Working capital	CNY 414.7M
Working capital turnover	10.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.95%
Dividend growth	0%
Dividend growth (3Y)	-12.64%
Dividend growth (5Y)	8.45%
Dividend growth years	0
Dividend payment date	2026-07-07
Dividend payment years	8
Dividend payout frequency	Annual
Dividend per share	CNY 0.20
Dividend yield	0.51%
Ex-dividend date	2026-07-07
FCF payout ratio	2,592.29%
Last dividend	CNY 0.20
Payout ratio	32.97%
Shareholder yield	-2.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CNY 34.28
1D price change	6.31%
1M price change	-9.17%
1M total return	-9.17%
1W price change	2.09%
1W total return	2.09%
1Y price change	22.44%
1Y return CAGR	23.25%
1Y total return	23.24%
20-day SMA	CNY 40.54
200-day SMA	CNY 33.15
3M price change	1.91%
3M total return	1.91%
3Y price change	34.16%
3Y return CAGR	11.22%
3Y total return	37.57%
50-day SMA	CNY 43.10
50-day SMA vs 200-day SMA	50over200
52-week high	CNY 53.57
52-week high date	2026-08-20
52-week low	CNY 21.01
52-week low date	2026-06-12
5Y price change	-49.9%
5Y return CAGR	-12.27%
5Y total return	-48.04%
6M price change	34.71%
6M total return	35.59%
All-time high	CNY 108.71
All-time high date	2021-08-05
All-time low	CNY 4.08
All-time low date	2019-01-28
Average true range (ATR)	CNY 2.49
Average volume	40.1M
Beta (1Y)	0.08
Beta (2Y)	0.59
Beta (5Y)	0.68
Change from 52-week high	-26.08%
Change from 52-week low	88.48%
Change from all-time high	-63.66%
Change from all-time low	867.43%
Change from open	8.49%
Day's gap	-2.01%
Dollar volume	CNY 2B
High price	CNY 40.15
Low price	CNY 36.50
Monthly RSI	58.42
Open price	CNY 36.50
Position in 52-week range	84.93%
Previous close	CNY 37.25
Price vs 150-day SMA	15.27%
Price vs 20-day SMA	-2.53%
Price vs 200-day SMA	19.19%
Price vs 50-day SMA	-8.33%
Relative volume	1.25
RSI	46.92
Sharpe ratio	0.74
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	-0.13
Sortino ratio	1.39
Sortino ratio (3Y)	0.81
Sortino ratio (5Y)	-0.08
Volume	50M
Weekly RSI	54.69
YTD price change	38.97%
YTD total return	39.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	-0.07%
Shares change (YoY)	2.95%
Shares held by insiders	8.77%
Shares held by institutions	28.93%
Shares outstanding	1.8B

Deeper analysis on SHE/300759

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SHE/300759 report

Is a complete SHE/300759 research report available?

No complete published report is available for she/300759 (SHE/300759) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SHE/300759 (SHE/300759)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/300759

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/300759 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SHE/300759

Frequently asked questions